Indegene to pay up to $4,717,250 over faxes sent without consent
Summary
Indegene, Inc. agreed to pay up to $4,717,250 to settle a TCPA junk fax class action, TCPAWorld reported on Nov. 5, 2026. The class covers 18,869 recipients of a fax sent on or about February 7, 2020, that offered a $250 honorarium per eligible patient. TCPA damages run $500.00 to $1,500.0 per fax. The fax looked informational, but its purpose was potentially marketing.
TopCloserR Perspective
The takeaway
Fax is still a live channel in health and pharma, and so is the TCPA liability that comes with it. Calling an outreach piece "informational" won't save you if it's really an offer. Every fax sent without consent is a separate cost.
Who this affects
- In the role
- You own the lists and the send tools, so proof of consent for every fax and outbound channel sits with you.
- Aspiring
- Analysts and coordinators moving into sales or marketing ops — Learn how consent is captured, stored and checked; it's a skill that protects the company and gets noticed.
- In the role
- If your team sends faxes or blasts to healthcare offices, one campaign without consent can turn into a seven-figure settlement.
- Aspiring
- Senior reps stepping into team leadership — Know which outreach your team runs that needs prior consent before you sign off on any campaign.
Who usually handles this
- Audit every fax campaign for documented consentMarketing and Sales Operations
Pull the lists behind recent and planned fax sends and confirm you have consent on file for each recipient, or stop the send.
- Treat any "informational" piece with an offer as marketingSales Manager
If outreach includes a payment, honorarium or pitch, run it through the same consent check as an ad.
Recommendations
More Sales Legal & Compliance news